Keith Norris to Hypertension
This is a "connection" page, showing publications Keith Norris has written about Hypertension.
Connection Strength
6.993
-
Shen JI, Nicholas SB, Williams S, Norris KC. Evidence for and Against ACC/AHA 2017 Guideline for Target Systolic Blood Pressure of
View in: PubMed
Score: 0.423
Schneider RH, Myers HF, Marwaha K, Rainforth MA, Salerno JW, Nidich SI, Gaylord-King C, Alexander CN, Norris KC. Stress Reduction in the Prevention of Left Ventricular Hypertrophy: A Randomized Controlled Trial of Transcendental Meditation and Health Education in Hypertensive African Americans. Ethn Dis. 2019; 29(4):577-586.
Score: 0.420
Shen JI, Norris KC. Is chronic kidney disease keeping the heart up all night? J Clin Hypertens (Greenwich). 2019 01; 21(1):88-90.
Score: 0.398
Norris KC, Edwina Barnett M, Meng YX, Martins D, Nicholas SB, Gibbons GH, Lee JE. Rationale and design of a placebo controlled randomized trial to assess short term, high-dose oral cholecalciferol on select laboratory and genomic responses in African Americans with hypovitaminosis D. Contemp Clin Trials. 2018 09; 72:20-25.
Score: 0.386
Mensah GA, Norris KC. Advancing Health Equity: Honoring the Legacy of Dr. Elijah B. Saunders. Ethn Dis. 2015 Nov 05; 25(4):381-2.
Score: 0.320
Norris KC, Nicholas SB. Strategies for Controlling Blood Pressure and Reducing Cardiovascular Disease Risk in Patients with Chronic Kidney Disease. Ethn Dis. 2015 Nov 05; 25(4):515-20.
Score: 0.320
Norris KC, Brown AF. The Highs and Lows of Blood Pressure Targets in Elderly Adults and Other High-Risk Populations. J Am Geriatr Soc. 2015 Oct; 63(10):2139-41.
Score: 0.318
Nicholas SB, Vaziri ND, Norris KC. What should be the blood pressure target for patients with chronic kidney disease? Curr Opin Cardiol. 2013 Jul; 28(4):439-45.
Score: 0.272
Martins D, Agodoa L, Norris KC. Hypertensive chronic kidney disease in African Americans: strategies for improving care. Cleve Clin J Med. 2012 Oct; 79(10):726-34.
Score: 0.258
Ferdinand KC, Norris KC. Eliminating disparities in hypertension, metabolic syndrome, kidney failure, and cardiovascular disease: basic science, clinical practice and community initiatives. Foreword. Ethn Dis. 2009; 19(4 Suppl 5):S5iii-iv.
Score: 0.199
Duru OK, Li S, Jurkovitz C, Bakris G, Brown W, Chen SC, Collins A, Klag M, McCullough PA, McGill J, Narva A, Pergola P, Singh A, Norris K. Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2008 Feb; 51(2):192-8.
Score: 0.187
Norris K, Neutel JM. Emerging insights in the first-step use of antihypertensive combination therapy. J Clin Hypertens (Greenwich). 2007 Dec; 9(12 Suppl 5):5-14.
Score: 0.185
Duru OK, Vargas RB, Kermah D, Pan D, Norris KC. Health insurance status and hypertension monitoring and control in the United States. Am J Hypertens. 2007 Apr; 20(4):348-53.
Score: 0.176
Norris KC, Greene T, Kopple J, Lea J, Lewis J, Lipkowitz M, Miller P, Richardson A, Rostand S, Wang X, Appel LJ. Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease. J Am Soc Nephrol. 2006 Oct; 17(10):2928-36.
Score: 0.169
Martins D, Norris K. Hypertension treatment in African Americans: physiology is less important than sociology. Cleve Clin J Med. 2004 Sep; 71(9):735-43.
Score: 0.147
Martins D, Tareen N, Nicholas SB, Jones L, Norris KC. Education, motivation and medication for African Americans: bringing hypertension guidelines to practice. Ethn Dis. 2004; 14(4):S2-38-41.
Score: 0.141
Nicholas SB, Tareen N, Martins D, Norris KC. Calcium antagonists: a more expansive role in treating persons with reduced kidney function? Ethn Dis. 2004; 14(4):S2-42-5.
Score: 0.141
Martins D, Tareen N, Pan D, Norris K. The relationship between body mass index, blood pressure and pulse rate among normotensive and hypertensive participants in the third National Health and Nutrition Examination Survey (NHANES). Cell Mol Biol (Noisy-le-grand). 2003 Dec; 49(8):1305-9.
Score: 0.140
Chang TI, Li S, Chen SC, Peralta CA, Shlipak MG, Fried LF, Whaley-Connell AT, McCullough PA, Kurella Tamura M. Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2013 04; 61(4 Suppl 2):S4-11.
Score: 0.134
Thomas Tobin CS, Guti?rrez ?, Norris KC, Thorpe RJ. Discrimination, Racial Identity, and Hypertension Among Black Americans Across Young, Middle, and Older Adulthood. J Gerontol B Psychol Sci Soc Sci. 2022 11 23; 77(11):1990-2005.
Score: 0.130
Pagi R, Yadin O, Wesseling-Perry K, Norris K, Laster ML. Racial-ethnic diversity in ambulatory blood pressure monitoring in children with chronic kidney disease. Pediatr Nephrol. 2023 03; 38(3):819-827.
Score: 0.127
Martins D, Tareen N, Pan D, Norris K. The relationship between body mass index and pulse pressure in older adults with isolated systolic hypertension. Am J Hypertens. 2002 Jun; 15(6):538-43.
Score: 0.126
Norris KC, Thornhill-Joynes M, Robinson C, Strickland T, Alperson BL, Witana SC, Ward HJ. Cocaine use, hypertension, and end-stage renal disease. Am J Kidney Dis. 2001 Sep; 38(3):523-8.
Score: 0.120
Martins D, Gor D, Teklehaimanot S, Norris K. High blood pressure knowledge in an urban African-American community. Ethn Dis. 2001; 11(1):90-6.
Score: 0.114
Martins D, Nelson K, Pan D, Tareen N, Norris K. The effect of gender on age-related blood pressure changes and the prevalence of isolated systolic hypertension among older adults: data from NHANES III. J Gend Specif Med. 2001; 4(3):10-3, 20.
Score: 0.114
Norris KC, Duru OK, Alicic RZ, Daratha KB, Nicholas SB, McPherson SM, Bell DS, Shen JI, Jones CR, Moin T, Waterman AD, Neumiller JJ, Vargas RB, Bui AAT, Mangione CM, Tuttle KR. Rationale and design of a multicenter Chronic Kidney Disease (CKD) and at-risk for CKD electronic health records-based registry: CURE-CKD. BMC Nephrol. 2019 11 20; 20(1):416.
Score: 0.106
Weinberg JM, Appel LJ, Bakris G, Gassman JJ, Greene T, Kendrick CA, Wang X, Lash J, Lewis JA, Pogue V, Thornley-Brown D, Phillips RA. Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy. Arch Intern Med. 2009 Sep 28; 169(17):1587-94.
Score: 0.105
Bruce MA, Beech BM, Norris KC, Griffith DM, Sims M, Thorpe RJ. Sex, Obesity, and Blood Pressure Among African American Adolescents: The Jackson Heart KIDS Pilot Study. Am J Hypertens. 2017 Sep 01; 30(9):892-898.
Score: 0.091
Norris KC. Health Insurance and Blood Pressure Control. J Am Heart Assoc. 2016 12 21; 5(12).
Score: 0.086
Ku E, Gassman J, Appel LJ, Smogorzewski M, Sarnak MJ, Glidden DV, Bakris G, Guti?rrez OM, Hebert LA, Ix JH, Lea J, Lipkowitz MS, Norris K, Ploth D, Pogue VA, Rostand SG, Siew ED, Sika M, Tisher CC, Toto R, Wright JT, Wyatt C, Hsu CY. BP Control and Long-Term Risk of ESRD and Mortality. J Am Soc Nephrol. 2017 02; 28(2):671-677.
Score: 0.084
Norris KC, Owen WF. The dilemma of hypertension in the ESRD African American community. Nephrol News Issues. 1995 Mar; 9(3):14-6, 24-5, 38.
Score: 0.076
Porter A, Fischer MJ, Wang X, Brooks D, Bruce M, Charleston J, Cleveland WH, Dowie D, Faulkner M, Gassman J, Hiremath L, Kendrick C, Kusek JW, Norris KC, Thornley-Brown D, Greene T, Lash JP. Quality of life and outcomes in African Americans with CKD. J Am Soc Nephrol. 2014 Aug; 25(8):1849-55.
Score: 0.072
Peralta CA, Norris KC, Li S, Chang TI, Tamura MK, Jolly SE, Bakris G, McCullough PA, Shlipak M. Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP). Arch Intern Med. 2012 Jan 09; 172(1):41-7.
Score: 0.061
Porter A, Fischer MJ, Brooks D, Bruce M, Charleston J, Cleveland WH, Dowie D, Faulkner M, Gassman J, Greene T, Hiremath L, Kendrick C, Kusek JW, Thornley-Brown D, Wang X, Norris K, Unruh M, Lash J. Quality of life and psychosocial factors in African Americans with hypertensive chronic kidney disease. Transl Res. 2012 Jan; 159(1):4-11.
Score: 0.060
Appel LJ, Wright JT, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010 Sep 02; 363(10):918-29.
Score: 0.056
Alves TP, Wang X, Wright JT, Appel LJ, Greene T, Norris K, Lewis J. Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis. J Am Soc Nephrol. 2010 Aug; 21(8):1361-9.
Score: 0.055
Norris KC, Nemeh MN, Kert CJ, Muallem S, Levine BS. Basal and stimulated cytosolic platelet calcium in essential hypertension. J Hum Hypertens. 1990 Apr; 4(2):110-2.
Score: 0.054
Bhatnagar V, Garcia EP, O'Connor DT, Brophy VH, Alcaraz J, Richard E, Bakris GL, Middleton JP, Norris KC, Wright J, Hiremath L, Contreras G, Appel LJ, Lipkowitz MS. CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease. Am J Nephrol. 2010; 31(2):95-103.
Score: 0.053
Appel LJ, Wright JT, Greene T, Kusek JW, Lewis JB, Wang X, Lipkowitz MS, Norris KC, Bakris GL, Rahman M, Contreras G, Rostand SG, Kopple JD, Gabbai FB, Schulman GI, Gassman JJ, Charleston J, Agodoa LY. Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med. 2008 Apr 28; 168(8):832-9.
Score: 0.047
Bhatnagar V, O'Connor DT, Schork NJ, Salem RM, Nievergelt CM, Rana BK, Smith DW, Bakris GL, Middleton JP, Norris KC, Wright JT, Cheek D, Hiremath L, Contreras G, Appel LJ, Lipkowitz MS. Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial. J Hypertens. 2007 Oct; 25(10):2082-92.
Score: 0.046
Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007 Jun 11; 167(11):1159-65.
Score: 0.045
Norris K, Bourgoigne J, Gassman J, Hebert L, Middleton J, Phillips RA, Randall O, Rostand S, Sherer S, Toto RD, Wright JT, Wang X, Greene T, Appel LJ, Lewis J. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Am J Kidney Dis. 2006 Nov; 48(5):739-51.
Score: 0.043
Phillips RA, Faulkner M, Gassman J, Jaen L, Kusek JW, Norris K, Ojo A. Recruitment of African Americans with chronic renal insufficiency into a multicenter clinical trial: the african american study of kidney disease and hypertension. J Clin Hypertens (Greenwich). 2004 Aug; 6(8):430-6.
Score: 0.037
Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med. 2013 Dec 05; 369(23):2183-96.
Score: 0.035
Appel LJ, Middleton J, Miller ER, Lipkowitz M, Norris K, Agodoa LY, Bakris G, Douglas JG, Charleston J, Gassman J, Greene T, Jamerson K, Kusek JW, Lewis JA, Phillips RA, Rostand SG, Wright JT. The rationale and design of the AASK cohort study. J Am Soc Nephrol. 2003 Jul; 14(7 Suppl 2):S166-72.
Score: 0.034
Lea JP, Brown DT, Lipkowitz M, Middleton J, Norris K. Preventing renal dysfunction in patients with hypertension: clinical implications from the early AASK Trial results. Am J Cardiovasc Drugs. 2003; 3(3):193-200.
Score: 0.033
Martins D, Tareen N, Norris KC. The epidemiology of end-stage renal disease among African Americans. Am J Med Sci. 2002 Feb; 323(2):65-71.
Score: 0.031
Bhavsar NA, Appel LJ, Kusek JW, Contreras G, Bakris G, Coresh J, Astor BC. Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. Am J Kidney Dis. 2011 Dec; 58(6):886-93.
Score: 0.030
Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER, Norris K, O'Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT, Xu S. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA. 2001 Jun 06; 285(21):2719-28.
Score: 0.029
Schneider RH, Castillo-Richmond A, Alexander CN, Myers H, Kaushik V, Aranguri C, Norris K, Haney C, Rainforth M, Calderon R, Nidich S. Behavioral treatment of hypertensive heart disease in African Americans: rationale and design of a randomized controlled trial. Behav Med. 2001; 27(2):83-95.
Score: 0.029
Contreras G, Hu B, Astor BC, Greene T, Erlinger T, Kusek JW, Lipkowitz M, Lewis JA, Randall OS, Hebert L, Wright JT, Kendrick CA, Gassman J, Bakris G, Kopple JD, Appel LJ. Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular disease. J Am Soc Nephrol. 2010 Dec; 21(12):2131-42.
Score: 0.028
Lee JY, Kusek JW, Greene PG, Bernhard S, Norris K, Smith D, Wilkening B, Wright JT. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens. 1996 Aug; 9(8):719-25.
Score: 0.021
Husaini BA, Levine RS, Norris KC, Cain V, Bazargan M, Moonis M. Heart Failure Hospitalization by Race/Ethnicity, Gender and Age in California: Implications for Prevention. Ethn Dis. 2016 07 21; 26(3):345-54.
Score: 0.021
Fischer MJ, Kimmel PL, Greene T, Gassman JJ, Wang X, Brooks DH, Charleston J, Dowie D, Thornley-Brown D, Cooper LA, Bruce MA, Kusek JW, Norris KC, Lash JP. Elevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease. Kidney Int. 2011 Sep; 80(6):670-8.
Score: 0.015
Lea JP, Norris K, Agodoa L. The role of anemia management in improving outcomes for African-Americans with chronic kidney disease. Am J Nephrol. 2008; 28(5):732-43.
Score: 0.012
McCullough PA, Jurkovitz CT, Pergola PE, McGill JB, Brown WW, Collins AJ, Chen SC, Li S, Singh A, Norris KC, Klag MJ, Bakris GL. Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med. 2007 Jun 11; 167(11):1122-9.
Score: 0.011
Agodoa L, Norris K, Pugsley D. The disproportionate burden of kidney disease in those who can least afford it. Kidney Int Suppl. 2005 Aug; (97):S1-3.
Score: 0.010
Mehrotra R, Budoff M, Christenson P, Ipp E, Takasu J, Gupta A, Norris K, Adler S. Determinants of coronary artery calcification in diabetics with and without nephropathy. Kidney Int. 2004 Nov; 66(5):2022-31.
Score: 0.009
Bottoli I, Beharry K, Modanlou HD, Norris K, Ling E, Noya F, Amato MM, Aranda JV. Effect of group B streptococcal meningitis on retinal and choroidal blood flow in newborn pigs. Invest Ophthalmol Vis Sci. 1995 Jun; 36(7):1231-9.
Score: 0.005